BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32119956)

  • 1. Detection of C. difficile toxin as a model assay for performing fully automated high-throughput RT-PCR on clinical stool samples.
    Eigner U; Nörz D; Reucher S; Furrer J; Sun J; Chu K; Kolb M; Hefner N; Pfefferle S; Lütgehetmann M
    J Microbiol Methods; 2020 May; 172():105882. PubMed ID: 32119956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Clostridioides difficile toxin B gene in clinical stool specimens using rapid diagnostic quenching probe-polymerase chain reaction assay.
    Hara Y; Nakamura K; Tanno D; Toyokawa M; Suzuki H; Ohashi K; Harada R; Hidaka T; Nagano T; Torii K; Kanemitsu K
    J Microbiol Methods; 2023 Feb; 205():106666. PubMed ID: 36608708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected
    Krutova M; Briksi A; Tkadlec J; Zajac M; Matejkova J; Nyc O; Drevinek P
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31391230
    [No Abstract]   [Full Text] [Related]  

  • 7. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
    Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples.
    Elfassy A; Kalina WV; French R; Nguyen H; Tan C; Sebastian S; Wilcox MH; Davies K; Kutzler MA; Jansen KU; Anderson A; Pride MW
    Anaerobe; 2021 Oct; 71():102415. PubMed ID: 34298152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.
    Luna RA; Boyanton BL; Mehta S; Courtney EM; Webb CR; Revell PA; Versalovic J
    J Clin Microbiol; 2011 Mar; 49(3):851-7. PubMed ID: 21209161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
    Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
    J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection.
    Hicke B; Pasko C; Groves B; Ager E; Corpuz M; Frech G; Munns D; Smith W; Warcup A; Denys G; Ledeboer NA; Lindsey W; Owen C; Rea L; Jenison R
    J Clin Microbiol; 2012 Aug; 50(8):2681-7. PubMed ID: 22675134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of loop-mediated isothermal amplification assay for detection of Clostridioides difficile infection: A prospective diagnostic performance study.
    Girão ES; Vásconez Noguera SL; Sanchez Espinoza EP; Pereira Alves Madeira Bezerra CL; Lino FM; Côrtes MF; Alves Dos Santos S; Paranhos-Baccala G; Perdigão Neto LV; Costa SF
    Anaerobe; 2021 Oct; 71():102410. PubMed ID: 34174401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rectal swabs and fecal samples for the detection of
    Huletsky A; Loo VG; Longtin Y; Longtin J; Trottier S; Tremblay CL; Gilca R; Lavallée C; Brochu É; Bérubé È; Bastien M; Bernier M; Gagnon M; Frenette J; Bestman-Smith J; Deschênes L; Bergeron MG
    Microbiol Spectr; 2024 Jun; 12(6):e0022524. PubMed ID: 38687067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
    Hirvonen JJ; Mentula S; Kaukoranta SS
    J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes.
    Hetem DJ; Bos-Sanders I; Nijhuis RHT; Tamminga S; Berlinger L; Kuijper EJ; Sickler JJ; Claas ECJ
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944191
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
    Leslie JL; Cohen SH; Solnick JV; Polage CR
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile.
    Couturier B; Schlaberg R; Konzak C; Nicholes J; Law C; She RC
    J Clin Lab Anal; 2013 May; 27(3):171-6. PubMed ID: 23686774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.